Detalles de la búsqueda
1.
Caregiver-reported quality of communication in pancreatic and periampullary cancer.
Cancer
; 130(11): 2051-2059, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38146683
2.
Predictors of Financial Toxicity Risk Among Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC).
Ann Surg Oncol
; 31(3): 1980-1989, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38044348
3.
Adoption of an Enhanced Recovery After Surgery Protocol Increases Cost of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy and Does not Improve Outcomes.
Ann Surg Oncol
; 2024 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38777898
4.
Intra- and Interpatient Drug Response Heterogeneity Exist in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Nongynecologic Cancers.
Ann Surg Oncol
; 31(3): 1996-2007, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38175427
5.
Preoperative CA 19-9 Predicts Disease Progression in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC Collaborative.
Ann Surg Oncol
; 31(5): 3314-3324, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38310181
6.
Surgeon-reported Factors Influencing Adoption of Quality Standards for Goal-concordant Care in Patients With Advanced Cancer: A Qualitative Study.
Ann Surg
; 277(5): e1000-e1005, 2023 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35766368
7.
Palliative Therapies in Metastatic Pancreatic Cancer: Does Medicaid Expansion Make a Difference?
Ann Surg Oncol
; 30(1): 179-188, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36169753
8.
Conditional Survival Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: An Analysis from the US HIPEC Collaborative.
Ann Surg Oncol
; 30(3): 1840-1849, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36310315
9.
Neighborhood-Level Socioeconomic Disadvantage Predicts Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignancy.
Ann Surg Oncol
; 30(12): 7840-7847, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37620532
10.
Validation of the AJCC 8th Edition Staging System for Disseminated Appendiceal Cancer Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Multi-institutional Analysis.
Ann Surg Oncol
; 30(9): 5743-5753, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37294386
11.
Prediction of Early Recurrence Following CRS/HIPEC in Patients With Disseminated Appendiceal Cancer.
J Surg Res
; 292: 275-288, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37666090
12.
Tumor deposits are associated with a higher risk of peritoneal disease in non-metastatic colorectal cancer patients.
J Surg Oncol
; 127(6): 975-982, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36790093
13.
Influence of insurance status on the postoperative outcomes of cytoreductive surgery and HIPEC.
J Surg Oncol
; 127(4): 706-715, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36468401
14.
Dissemination and Implementation of a Community Health Worker Intervention for Disparities in Palliative Care (DeCIDE PC): a study protocol for a hybrid type 1 randomized controlled trial.
BMC Palliat Care
; 22(1): 139, 2023 Sep 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37718442
15.
Bias Issues in Colorectal Cancer Management: A Review.
Ann Surg Oncol
; 29(4): 2166-2173, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34142287
16.
Disparities in Access to Oncologic Care in Pancreatic Cancer: A Systematic Review.
Ann Surg Oncol
; 29(5): 3232-3250, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35067789
17.
Breast Cancer Risk and Screening in Transgender Persons: A Call for Inclusive Care.
Ann Surg Oncol
; 29(4): 2176-2180, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34097159
18.
Association of Medicaid Expansion with Pancreatic Cancer Treatment and Outcomes: Evidence from the National Cancer Database.
Ann Surg Oncol
; 29(1): 342-351, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34453259
19.
Is Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy Still Indicated in Patients With Extraperitoneal Disease?
J Surg Res
; 277: 269-278, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35525209
20.
Current role for cytoreduction and HIPEC for gastric cancer with peritoneal disease.
J Surg Oncol
; 125(7): 1176-1182, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35481913